Bio-Rad Laboratories (NYSE:BIO.B) Reaches New 52-Week Low at $268.24

Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO.B) hit a new 52-week low on Tuesday . The stock traded as low as $268.24 and last traded at $268.88, with a volume of 42 shares trading hands. The stock had previously closed at $283.45.

Bio-Rad Laboratories Price Performance

The firm has a 50 day moving average of $281.71 and a 200 day moving average of $309.54. The company has a debt-to-equity ratio of 0.13, a quick ratio of 4.89 and a current ratio of 6.57.

Bio-Rad Laboratories (NYSE:BIO.B) last announced its quarterly earnings data on Tuesday, May 7th. The company reported $2.29 EPS for the quarter. Bio-Rad Laboratories had a positive return on equity of 3.59% and a negative net margin of 12.37%. The firm had revenue of $610.82 million during the quarter.

Bio-Rad Laboratories Company Profile

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.